Four Stocks to Beat the Market in 2025

  • 📰 CNBC
  • ⏱ Reading Time:
  • 82 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 53%
  • Publisher: 72%

INVESTING Nouvelles

STOCK MARKET,INVESTING OPPORTUNITIES,BEAUTY INDUSTRY

Market strategist Michele Schneider identifies four stocks, including Ulta Beauty and AbbVie, poised for success in 2025.

The outlook for equity markets this year looks uncertain, with one market strategist describing the new year as 'stepping into a house of cards.' The stock market may fluctuate in 2025, but significant opportunities will arise for those focused on individual stock picks, Michele Schneider, chief market strategist at Marketgauge.com, noted.

The sell-off in December could impact near-term sentiment, but patience may be key to capitalizing on opportunities when the market resets in January, she added in an outlook note. From beauty labels to electric vehicle companies, here are four stocks Schneider expects to beat the market this year. Ulta Beauty Among Schneider's top picks is Ulta Beauty , a U.S. retailer specializing in beauty and cosmetics products. The company operates an e-commerce platform and has over 1,000 stores across the U.S., making it one of the largest beauty retailers in the country, the strategist said. She also likes its AI-powered features such as its recently launched Ulta Beauty Virtual Artist, which enables consumers to try on makeup virtually. Shares in Ulta Beauty have lost around 9.4% over the last 12 months. According to FactSet data, analysts' average price target on the stock is $429.16, which implies 3.6% upside. AbbVie Elsewhere in the beauty and healthcare space, Schneider is betting on pharmaceutical giant AbbVie , which works across aesthetics, immunology, oncology and neuroscience. The strategist is particularly keen on its aesthetics division, given that it owns Botox-maker, Allergan. 'Botox is one of the most well-known and widely used aesthetic treatments globally, primarily known for its cosmetic use in reducing wrinkles and fine lines,' she explained, meaning it fits into the 'vanity trade.' Shares in AbbVie are up around 11.8% over the last 12 months. Just over 60% of analysts covering the stock give it a buy or overweight rating, according to FactSet data. Their average price target of $17

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 12. in BE
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Stock market today: Asian stocks gain after Wall Street opens 2025 with modest lossesAsian markets have opened with gains after U.S. stock indexes slipped as Wall Street’s weak end to last year carried into 2025.
La source: wjxt4 - 🏆 246. / 63 Lire la suite »

Stock market today: Asian stocks gain after Wall Street opens 2025 with modest lossesAsian markets rose on Friday after U.S. stock indexes slipped as Wall Street’s weak end to last year carried into 2025. U.S. futures and oil prices rose.
La source: Mynorthwest - 🏆 438. / 53 Lire la suite »

These stocks, including Nvidia, are among Bank of America’s top stocks to buy in 2025Bank of America names its favorite stocks for the new year.
La source: CNBC - 🏆 12. / 72 Lire la suite »